Finance

Cord Partners' parent company commences trading

Published in Genomics and Genetics Weekly, March 4th, 2005

Cord Blood America, Inc., announced that it has received National Association of Securities Dealers' approval to commence trading on the Nasdaq Over the Counter Bulletin board effective immediately.

The company's common stock will trade under the symbol CBAI.

Cord Blood America is the parent company of Cord Partners, which facilitates umbilical cord-blood stem-cell preservation for expectant parents and their children. Collected through a safe and noninvasive process, cord-blood stem cells offer a powerful and life-saving resource for treating a growing number of ailments such as leukemia, anemia, and certain types of cancers. Founded in 2002 by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly

Source: Genomics and Genetics Weekly (2005-03-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry